STOCK TITAN

Danaher (NYSE: DHR) SVP awarded 41 deferred stock units in comp plan

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Danaher Corporation insider compensation update: SVP-Chief Legal Officer Jonathan Leiken was credited with 41 notional shares in the Danaher Stock Fund under the company’s deferred compensation program on 02/02/2026. These notional shares are valued using the $218.89 NYSE closing price and convert into Danaher common stock on a one-for-one basis under the plan’s terms.

Positive

  • None.

Negative

  • None.
Insider Leiken Jonathan
Role SVP-Chief Legal Officer
Type Security Shares Price Value
Grant/Award Danaher Deferred Compensation Programs - Danaher Stock Fund 41 $218.89 $9K
Holdings After Transaction: Danaher Deferred Compensation Programs - Danaher Stock Fund — 41 shares (Direct)
Footnotes (1)
  1. Represents the Company's annual contribution to the Danaher stock fund in the reporting person's account under one or more of the plans that form part of Danaher's deferred compensation program. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Danaher common stock. The price shown in Table II, Column 8 is the closing price per share of Danaher common stock as reported on the NYSE on the date used to determine the number of notional shares to be credited to the participant's account. The notional shares convert on a one-for-one basis. The vesting terms and manner and form of distribution of amounts contributed or deferred under the program are based upon the provisions of the respective plan, which provisions are summarized in the latest Danaher Corporation annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Leiken Jonathan

(Last) (First) (Middle)
2200 PENNSYLVANIA AVE NW
SUITE 800W

(Street)
WASHINGTON DC 20037

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
DANAHER CORP /DE/ [ DHR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP-Chief Legal Officer
3. Date of Earliest Transaction (Month/Day/Year)
02/02/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Danaher Deferred Compensation Programs - Danaher Stock Fund(1) (2) 02/02/2026 A 41 (3) (3) Common Stock 41 $218.89 41 D
Explanation of Responses:
1. Represents the Company's annual contribution to the Danaher stock fund in the reporting person's account under one or more of the plans that form part of Danaher's deferred compensation program. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Danaher common stock. The price shown in Table II, Column 8 is the closing price per share of Danaher common stock as reported on the NYSE on the date used to determine the number of notional shares to be credited to the participant's account.
2. The notional shares convert on a one-for-one basis.
3. The vesting terms and manner and form of distribution of amounts contributed or deferred under the program are based upon the provisions of the respective plan, which provisions are summarized in the latest Danaher Corporation annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission.
Remarks:
/s/ James F. O'Reilly, attorney-in-fact for Jonathan Leiken 02/04/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Danaher (DHR) report in this Form 4 for Jonathan Leiken?

Danaher reported that SVP-Chief Legal Officer Jonathan Leiken received 41 notional shares in the Danaher Stock Fund on 02/02/2026. These were company contributions under its deferred compensation program, tied to Danaher common stock value rather than an open-market purchase.

How many deferred stock units did the Danaher (DHR) SVP receive?

The SVP-Chief Legal Officer received 41 notional shares credited to his Danaher Stock Fund account. These notional shares are part of Danaher’s deferred compensation program and are designed to mirror the value of Danaher common stock over time under the plan’s rules.

What price was used for the Danaher (DHR) notional shares in this Form 4?

The notional shares were valued using a price of $218.89 per share, which was the NYSE closing price of Danaher common stock on the date used to determine the number of notional shares credited under the deferred compensation program.

Do the Danaher (DHR) notional shares convert into common stock?

Yes. The filing states that the notional shares convert into Danaher common stock on a one-for-one basis. The specific vesting, timing, and distribution mechanics follow the provisions of Danaher’s deferred compensation plans described in its latest proxy statement.

Was this Danaher (DHR) Form 4 an open-market stock purchase or sale?

No. The transaction reflects a company contribution under Danaher’s deferred compensation program, not an open-market trade. The 41 notional shares are unfunded bookkeeping entries that track Danaher common stock value rather than directly bought or sold shares.

What role does Jonathan Leiken hold at Danaher (DHR) in this Form 4?

Jonathan Leiken is identified as an officer of Danaher, serving as SVP-Chief Legal Officer. The reported transaction concerns the company’s annual contribution to his account in the Danaher Stock Fund within its broader deferred compensation program.